URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

James Mason

Concepts (348)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Telomere
12
2002
27
4.740
Why?
Drosophila melanogaster
10
2002
65
3.470
Why?
Hypertension
7
2003
300
2.310
Why?
Drosophila Proteins
5
2002
80
2.100
Why?
Drosophila
3
2004
80
1.580
Why?
DNA Breaks, Double-Stranded
2
2009
23
1.470
Why?
Retroelements
6
2003
30
1.230
Why?
DNA-Binding Proteins
3
2008
687
1.130
Why?
Chromosomal Proteins, Non-Histone
4
2002
16
1.120
Why?
Diabetes Mellitus
4
2003
169
1.110
Why?
Pancreatitis
2
2007
29
0.900
Why?
Life Style
5
2004
87
0.890
Why?
Gene Silencing
4
2003
40
0.800
Why?
Wound Healing
5
2003
211
0.790
Why?
Heterochromatin
3
2002
15
0.770
Why?
Practice Guidelines as Topic
4
2004
304
0.770
Why?
Evidence-Based Medicine
5
2002
199
0.750
Why?
DNA Transposable Elements
3
2002
44
0.740
Why?
Chromosomes
3
2005
40
0.720
Why?
Cost-Benefit Analysis
4
2004
209
0.650
Why?
Relaxation Therapy
1
2008
16
0.640
Why?
Animals
21
2001
16270
0.620
Why?
Hyperlipidemias
2
2003
46
0.610
Why?
Terminal Repeat Sequences
2
2003
6
0.590
Why?
Antihypertensive Agents
2
2004
82
0.590
Why?
Diabetes Mellitus, Experimental
2
2003
93
0.570
Why?
Severity of Illness Index
1
2010
919
0.560
Why?
Diabetes Complications
3
2003
66
0.560
Why?
Economics, Pharmaceutical
1
2006
6
0.550
Why?
Meta-Analysis as Topic
1
2006
35
0.550
Why?
Sodium Chloride Symporter Inhibitors
1
2005
10
0.540
Why?
Euchromatin
1
2005
1
0.540
Why?
Flavoproteins
1
2004
6
0.510
Why?
Adrenergic beta-Antagonists
1
2005
175
0.500
Why?
Amino Acid Oxidoreductases
1
2004
39
0.500
Why?
Diabetic Angiopathies
1
2005
35
0.500
Why?
Lysosomes
1
2004
49
0.490
Why?
Transduction, Genetic
2
2003
119
0.470
Why?
Femur Head Necrosis
1
2003
4
0.470
Why?
Cementation
1
2003
17
0.470
Why?
Transcription, Genetic
2
2007
815
0.470
Why?
Bone Cements
1
2003
15
0.460
Why?
Hip Prosthesis
1
2003
40
0.460
Why?
Cold Temperature
1
2003
96
0.460
Why?
Arthroplasty, Replacement, Hip
1
2003
46
0.450
Why?
Health Care Costs
1
2004
112
0.450
Why?
Leukocytes
1
2004
180
0.450
Why?
Humans
32
2002
36400
0.450
Why?
Hot Temperature
1
2003
161
0.440
Why?
Transgenes
4
2003
74
0.430
Why?
Mutation
4
2002
1229
0.420
Why?
Models, Biological
2
2003
1023
0.420
Why?
Gene Products, gag
1
2002
16
0.420
Why?
Transforming Growth Factor beta
2
2001
413
0.410
Why?
Immediate-Early Proteins
1
2001
34
0.400
Why?
Collagen Type I
1
2001
52
0.400
Why?
Growth Substances
1
2001
103
0.390
Why?
Cell Cycle
3
2009
248
0.380
Why?
Intercellular Signaling Peptides and Proteins
1
2001
117
0.380
Why?
DNA Repair
3
2009
174
0.370
Why?
Extracellular Matrix
1
2001
167
0.360
Why?
RNA, Messenger
2
2001
1857
0.330
Why?
Chromosome Mapping
3
2002
229
0.320
Why?
Base Sequence
4
2003
1704
0.320
Why?
Models, Genetic
3
2003
160
0.310
Why?
England
5
2002
45
0.310
Why?
Antioxidants
2
2007
203
0.310
Why?
Randomized Controlled Trials as Topic
4
2005
409
0.310
Why?
Meiosis
2
2004
28
0.300
Why?
Animals, Genetically Modified
2
2003
55
0.280
Why?
Molecular Sequence Data
3
2003
2028
0.270
Why?
Telephone
2
2005
22
0.260
Why?
Two-Hybrid System Techniques
2
2011
68
0.260
Why?
Immunoprecipitation
2
2011
90
0.250
Why?
Proto-Oncogene Proteins c-sis
2
2003
21
0.250
Why?
Specialties, Nursing
2
2003
3
0.250
Why?
Judgment
2
2005
14
0.250
Why?
Blood Pressure
3
2003
474
0.250
Why?
Female
14
2002
19826
0.240
Why?
Blotting, Southern
2
2002
101
0.240
Why?
Male
17
2002
19713
0.230
Why?
Ambulatory Care
2
2005
152
0.230
Why?
APACHE
2
2007
31
0.230
Why?
Trans-Activators
2
2003
364
0.220
Why?
Research Design
2
2012
333
0.220
Why?
Pancreatitis, Alcoholic
1
2012
1
0.220
Why?
Pancreatitis, Chronic
1
2012
1
0.220
Why?
Pyoderma Gangrenosum
1
2012
1
0.220
Why?
Quality of Life
4
2006
509
0.210
Why?
Prednisolone
1
2012
25
0.210
Why?
Diabetes Mellitus, Type 2
2
2005
225
0.210
Why?
Dermatologic Agents
1
2012
24
0.210
Why?
Leg Dermatoses
1
2011
6
0.210
Why?
Cellulitis
1
2011
12
0.210
Why?
Cyclosporine
1
2012
63
0.210
Why?
Penicillin V
1
2011
27
0.200
Why?
Middle Aged
10
2003
9877
0.200
Why?
Opioid-Related Disorders
1
2011
25
0.200
Why?
Governing Board
1
2011
2
0.200
Why?
Transfection
2
2004
876
0.200
Why?
Acute Disease
2
2007
580
0.200
Why?
Aged
9
2003
7272
0.200
Why?
State Medicine
1
2011
17
0.200
Why?
Preventive Medicine
1
2011
32
0.200
Why?
Mice
6
2001
6103
0.190
Why?
Venous Thrombosis
1
2011
83
0.190
Why?
Area Under Curve
1
2010
63
0.190
Why?
Protein Structure, Tertiary
2
2008
379
0.190
Why?
Aged, 80 and over
4
2005
2513
0.180
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2010
13
0.180
Why?
Physicians
1
2012
159
0.180
Why?
Genes, Insect
1
2009
6
0.170
Why?
Adult
8
2005
11345
0.170
Why?
Heart Failure
2
2002
389
0.170
Why?
Gene Expression Regulation
2
2003
875
0.170
Why?
Adult Stem Cells
1
2009
22
0.170
Why?
Delivery of Health Care
1
2011
145
0.170
Why?
Bone Regeneration
1
2009
37
0.170
Why?
Lentivirus
2
2005
27
0.170
Why?
Health Policy
2
2005
82
0.170
Why?
Glioma
1
2010
102
0.160
Why?
Pain
1
2012
382
0.160
Why?
Adrenal Cortex Hormones
1
2009
99
0.160
Why?
Psoriasis
1
2009
47
0.160
Why?
Bone Density Conservation Agents
1
2009
51
0.160
Why?
Species Specificity
1
2009
340
0.160
Why?
Skull
1
2009
127
0.160
Why?
Vitamin D
1
2009
70
0.160
Why?
Oocytes
1
2009
133
0.160
Why?
Drug Therapy, Combination
2
2005
390
0.160
Why?
Mutagenesis, Insertional
1
2008
53
0.150
Why?
Dermis
2
2003
7
0.150
Why?
Repetitive Sequences, Nucleic Acid
1
2008
80
0.150
Why?
Evolution, Molecular
1
2008
63
0.150
Why?
Sequence Homology
1
2007
14
0.150
Why?
Anti-Bacterial Agents
1
2011
436
0.150
Why?
Pyruvate Kinase
1
2007
26
0.150
Why?
Chromatin
1
2008
99
0.150
Why?
Treatment Outcome
6
2003
2623
0.150
Why?
Histones
1
2009
161
0.150
Why?
Group Processes
1
2006
16
0.140
Why?
Arsenicals
1
2006
7
0.140
Why?
Fertility
1
2006
49
0.140
Why?
Longevity
1
2006
27
0.140
Why?
Diet, Sodium-Restricted
1
2006
13
0.140
Why?
Review Literature as Topic
1
2006
8
0.140
Why?
Pancreatic Neoplasms
1
2007
84
0.140
Why?
Oxides
1
2006
23
0.140
Why?
Phenotype
1
2009
762
0.140
Why?
Internationality
1
2006
27
0.140
Why?
Polymerase Chain Reaction
2
2003
594
0.140
Why?
Hydrogen-Ion Concentration
2
2004
571
0.140
Why?
Femur
2
2003
86
0.140
Why?
Social Support
2
2005
228
0.140
Why?
Primary Health Care
1
2011
492
0.140
Why?
Gene Components
1
2005
1
0.140
Why?
Genomic Library
1
2005
15
0.140
Why?
Oligonucleotide Array Sequence Analysis
1
2008
284
0.140
Why?
Genes, sis
1
2005
1
0.140
Why?
Models, Economic
1
2006
27
0.130
Why?
Insurance, Health, Reimbursement
1
2006
32
0.130
Why?
Repressor Proteins
1
2008
181
0.130
Why?
Risk Factors
3
2005
2318
0.130
Why?
Nuclear Proteins
1
2009
330
0.130
Why?
Pigmentation
1
2004
5
0.130
Why?
Physician's Practice Patterns
2
2002
253
0.130
Why?
Apoptosis
1
2011
855
0.130
Why?
4-Aminobenzoic Acid
1
2004
1
0.130
Why?
Amino Acids, Aromatic
1
2004
2
0.130
Why?
Benzoic Acid
1
2004
3
0.130
Why?
L-Amino Acid Oxidase
1
2004
3
0.130
Why?
Microscopy, Electron
1
2005
385
0.130
Why?
NIH 3T3 Cells
1
2004
24
0.130
Why?
Computational Biology
1
2005
67
0.130
Why?
Sequence Analysis, DNA
1
2005
164
0.130
Why?
Cost Allocation
1
2004
2
0.120
Why?
HMGB1 Protein
1
2004
2
0.120
Why?
Fractures, Bone
1
2005
93
0.120
Why?
In Situ Hybridization
1
2005
314
0.120
Why?
Myelodysplastic Syndromes
1
2006
133
0.120
Why?
Health Care Rationing
1
2004
9
0.120
Why?
Subcellular Fractions
1
2004
100
0.120
Why?
Eye
1
2004
55
0.120
Why?
Genetic Markers
1
2004
132
0.120
Why?
Gastroenterology
1
2004
10
0.120
Why?
Mice, Inbred C57BL
3
2003
1683
0.120
Why?
Adolescent
2
2010
4752
0.120
Why?
Cell Line
1
2009
1594
0.120
Why?
Osteoporosis
1
2005
85
0.120
Why?
Binding, Competitive
1
2004
209
0.120
Why?
Quality-Adjusted Life Years
1
2004
50
0.120
Why?
DNA Primers
1
2005
414
0.120
Why?
Promoter Regions, Genetic
1
2007
552
0.120
Why?
Substrate Specificity
1
2004
246
0.120
Why?
Finite Element Analysis
1
2003
11
0.120
Why?
Patient-Centered Care
1
2005
77
0.120
Why?
Health Services Research
1
2004
118
0.120
Why?
Recombination, Genetic
1
2004
177
0.120
Why?
Immunohistochemistry
2
2003
1063
0.120
Why?
Retroviridae
1
2003
67
0.120
Why?
Oxidation-Reduction
1
2004
311
0.120
Why?
Double-Blind Method
3
2007
998
0.110
Why?
Eye Color
1
2003
1
0.110
Why?
Equipment Failure Analysis
1
2003
73
0.110
Why?
Blood Glucose
1
2005
467
0.110
Why?
Prosthesis Failure
1
2003
85
0.110
Why?
Periosteum
1
2003
24
0.110
Why?
Pharmacists
1
2002
6
0.110
Why?
Models, Chemical
1
2003
103
0.110
Why?
Temperature
1
2003
253
0.110
Why?
Patient Satisfaction
1
2005
230
0.110
Why?
Drug Utilization
1
2002
47
0.110
Why?
Enzyme Inhibitors
1
2004
438
0.110
Why?
Anaphase
1
2002
5
0.110
Why?
Metaphase
1
2002
13
0.110
Why?
Genes, Reporter
1
2003
207
0.100
Why?
Insect Proteins
1
2002
10
0.100
Why?
Education, Medical, Continuing
1
2002
65
0.100
Why?
Left-Right Determination Factors
1
2001
1
0.100
Why?
Connective Tissue Growth Factor
1
2001
2
0.100
Why?
Macrophages
1
2004
347
0.100
Why?
Algorithms
1
2006
537
0.100
Why?
Guideline Adherence
1
2002
83
0.100
Why?
Genes, Dominant
1
2002
80
0.100
Why?
DNA Probes
1
2002
88
0.100
Why?
Cartilage, Articular
1
2003
207
0.100
Why?
Fibrosarcoma
1
2001
27
0.100
Why?
Matrix Metalloproteinases
1
2001
35
0.100
Why?
Mitosis
1
2002
102
0.100
Why?
Recombinant Proteins
1
2004
768
0.100
Why?
Computer Simulation
1
2003
298
0.100
Why?
Stem Cell Transplantation
1
2003
113
0.100
Why?
Mice, Nude
1
2001
177
0.100
Why?
Kinetics
1
2004
1464
0.100
Why?
Transcriptional Activation
1
2003
288
0.100
Why?
Family Practice
1
2002
184
0.100
Why?
Polymorphism, Genetic
1
2002
199
0.090
Why?
Antineoplastic Agents
1
2006
625
0.090
Why?
Fibroblasts
1
2003
545
0.090
Why?
Prospective Studies
3
2006
1677
0.090
Why?
Recurrence
2
2011
697
0.090
Why?
Great Britain
2
2006
98
0.090
Why?
Program Evaluation
3
2003
205
0.090
Why?
Risk Assessment
3
2005
878
0.090
Why?
Protein Binding
2
2008
865
0.070
Why?
Young Adult
2
2011
1074
0.070
Why?
Infusions, Intravenous
2
2006
139
0.070
Why?
Drug Administration Schedule
2
2006
369
0.070
Why?
Time Factors
2
2012
3201
0.060
Why?
Survival Analysis
2
2006
598
0.060
Why?
Questionnaires
2
2005
998
0.060
Why?
Exercise
2
2005
182
0.060
Why?
Quality Assurance, Health Care
2
2004
119
0.060
Why?
Prognosis
2
2006
1080
0.060
Why?
Genetic Vectors
2
2005
339
0.060
Why?
Retrospective Studies
2
2007
2260
0.060
Why?
Ireland
1
2012
8
0.050
Why?
Drug Costs
1
2012
26
0.050
Why?
Leg Ulcer
1
2011
6
0.050
Why?
Uncertainty
1
2012
19
0.050
Why?
Costs and Cost Analysis
1
2011
87
0.050
Why?
Medication Adherence
1
2011
21
0.050
Why?
Antibiotic Prophylaxis
1
2011
31
0.050
Why?
Organizational Case Studies
1
2011
10
0.050
Why?
Decision Making, Organizational
1
2011
7
0.050
Why?
Administration, Oral
1
2012
309
0.050
Why?
Qualitative Research
1
2011
55
0.050
Why?
Focus Groups
1
2011
67
0.050
Why?
Heparin
1
2011
125
0.050
Why?
Pain Measurement
1
2012
243
0.050
Why?
Patient Selection
1
2012
209
0.050
Why?
Lucanthone
1
2010
1
0.050
Why?
Anticoagulants
1
2011
135
0.050
Why?
Cells, Cultured
2
2003
2563
0.040
Why?
Prevalence
1
2011
541
0.040
Why?
Biomedical Engineering
1
2009
14
0.040
Why?
Radiation Tolerance
1
2010
89
0.040
Why?
Motivation
1
2011
159
0.040
Why?
Indoles
1
2010
104
0.040
Why?
Incidence
1
2011
679
0.040
Why?
Administration, Topical
1
2009
89
0.040
Why?
Hospitalization
1
2011
377
0.040
Why?
Micrococcal Nuclease
1
2008
14
0.040
Why?
DNA Damage
1
2010
167
0.040
Why?
RNA, Small Interfering
1
2010
203
0.040
Why?
Nucleosomes
1
2008
80
0.040
Why?
Selenium
1
2007
38
0.040
Why?
Cell Line, Tumor
1
2010
576
0.040
Why?
Ascorbic Acid
1
2007
51
0.040
Why?
Acetylcysteine
1
2007
83
0.040
Why?
Chronic Disease
1
2009
530
0.040
Why?
Brain Neoplasms
1
2010
282
0.040
Why?
Ovary
1
2006
87
0.030
Why?
Fish Oils
1
2006
8
0.030
Why?
Hematologic Diseases
1
2006
37
0.030
Why?
Administrative Personnel
1
2006
22
0.030
Why?
Calcium, Dietary
1
2006
22
0.030
Why?
Gene Expression
1
2010
756
0.030
Why?
Azo Compounds
1
2005
18
0.030
Why?
Disease-Free Survival
1
2006
202
0.030
Why?
Rats, Sprague-Dawley
1
2009
1028
0.030
Why?
Data Interpretation, Statistical
1
2006
155
0.030
Why?
Sunlight
1
2005
15
0.030
Why?
Antigens, CD31
1
2005
27
0.030
Why?
Magnesium
1
2006
137
0.030
Why?
Consensus
1
2005
14
0.030
Why?
Coloring Agents
1
2005
56
0.030
Why?
Comprehension
1
2005
23
0.030
Why?
Mice, Inbred Strains
1
2005
242
0.030
Why?
Hemoglobin A, Glycosylated
1
2005
49
0.030
Why?
Staining and Labeling
1
2005
165
0.030
Why?
Tumor Markers, Biological
1
2007
228
0.030
Why?
Immunoenzyme Techniques
1
2005
220
0.030
Why?
Potassium
1
2006
306
0.030
Why?
Tumor Necrosis Factors
1
2004
16
0.030
Why?
Green Fluorescent Proteins
1
2005
218
0.030
Why?
Diet
1
2006
206
0.030
Why?
Cricetulus
1
2004
97
0.030
Why?
Software
1
2005
125
0.030
Why?
Mice, Inbred C3H
1
2004
229
0.030
Why?
DNA, Bacterial
1
2004
174
0.030
Why?
CHO Cells
1
2004
190
0.030
Why?
Patient Compliance
1
2005
171
0.030
Why?
Ambulatory Care Facilities
1
2003
33
0.030
Why?
Pilot Projects
1
2005
441
0.030
Why?
Bone Morphogenetic Protein 7
1
2003
7
0.030
Why?
Oxidative Stress
1
2007
352
0.030
Why?
Cricetinae
1
2004
389
0.030
Why?
Cholesterol
1
2003
139
0.030
Why?
Lipopolysaccharides
1
2004
209
0.030
Why?
Intervention Studies
1
2002
30
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
543
0.030
Why?
Analysis of Variance
1
2005
725
0.030
Why?
Knee Joint
1
2003
55
0.030
Why?
Hedgehog Proteins
1
2003
58
0.030
Why?
Organizational Innovation
1
2002
28
0.030
Why?
Community-Institutional Relations
1
2002
29
0.030
Why?
Tissue Engineering
1
2003
90
0.030
Why?
Bone Morphogenetic Proteins
1
2003
192
0.020
Why?
Rabbits
1
2003
704
0.020
Why?
Osteoarthritis
1
2002
150
0.020
Why?
Escherichia coli
1
2004
523
0.020
Why?
Rats
1
2009
4386
0.020
Why?
Disease Models, Animal
1
2005
973
0.020
Why?
Cytokines
1
2004
572
0.020
Why?
Follow-Up Studies
1
2005
1857
0.020
Why?
Depressive Disorder
1
2002
321
0.020
Why?
Cardiovascular Diseases
1
2002
276
0.020
Why?

Visualizations


Mason's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department